KRAS and colorectal cancer: To further explore the effect of RGD-p21Ras-scFv on downstream signaling pathways after inhibition of Ras activity, we analyzed the changes of MEK-ERK and PI3K-AKT signaling molecules in the above KRAS wild and KRAS mutant colorectal cancer cell lines by WB.